Sio Capital Management, LLC Essa Pharma Inc. Transaction History

Sio Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$7.76 - $29.37 $1.15 Million - $4.35 Million	-148,127 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$24.17 - $34.28 $3.98 Million - $5.64 Million	-164,584 Reduced 52.63%	148,127 $4.23 Million
Q1 2021 May 14, 2021	SELL	$11.61 - $32.08 $1.4 Million - $3.86 Million	-120,312 Reduced 27.78%	312,711 $9.08 Million
Q4 2020 Feb 16, 2021	SELL	$5.47 - $12.1 $1.22 Million - $2.7 Million	-223,020 Reduced 33.99%	433,023 $5.17 Million
Q3 2020 Nov 16, 2020	BUY	$6.0 - $7.79 $3.94 Million - $5.11 Million	656,043 New	656,043 $4.53 Million

35.1M

15.8K

21K

Ticker EPIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,073,100
Market Cap $80.7M
Description
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sio Capital Management, LLC with notifications on news.